Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction

European Journal of Neuroscience

Volumn 39, Issue 7, 2014, Pages 1189-1201

  Melis, Miriam ^a   Greco, Barbara ^b   Tonini, Raffaella ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Behavioral plasticity; Endocannabinoids; Experience dependent plasticity; Metaplasticity; Synapse modulation

Indexed keywords

ENDOCANNABINOID;

ARTICLE; BEHAVIOR; COGNITION; COGNITIVE DEFECT; ENDOCANNABINOID SIGNALING; HEALTH STATUS; HUMAN; METAPLASTICITY; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPSE; ANIMAL; METABOLISM; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; ENDOCANNABINOIDS; HUMANS; NEURONAL PLASTICITY; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84898713396     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12501     Document Type: Article

References (182)

1. Abbott, L.F. & Regehr, W.G. (2004) Synaptic computation. Nature, 431, 796-803.
2. Abbott, L.F., Varela, J.A., Sen, K. & Nelson, S.B. (1997) Synaptic depression and cortical gain control. Science, 275, 220-224.
3. Abraham, W.C. (2008) Metaplasticity: tuning synapses and networks for plasticity. Nat. Rev. Neurosci., 9, 387-399.
4. Abraham, W.C. & Bear, M.F. (1996) Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci., 19, 126-130.
5. Ade, K.K. & Lovinger, D.M. (2007) Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. J. Neurosci., 27, 2403-2409.
6. Adermark, L., Talani, G. & Lovinger, D.M. (2009) Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur. J. Neurosci., 29, 32-41.
7. Arnsten, A.F., Wang, M.J. & Paspalas, C.D. (2012) Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron, 76, 223-239.
8. Ashton, J.C., Friberg, D., Darlington, C.L. & Smith, P.F. (2006) Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci. Lett., 396, 113-116.
9. Azad, S.C., Monory, K., Marsicano, G., Cravatt, B.F., Lutz, B., Zieglgansberger, W. & Rammes, G. (2004) Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J. Neurosci., 24, 9953-9961.
10. Bacci, A., Huguenard, J.R. & Prince, D.A. (2004) Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature, 431, 312-316.
11. Bear, M.F. & Singer, W. (1986) Modulation of visual cortical plasticity by acetylcholine and noradrenaline. Nature, 320, 172-176.
12. Beltramo, M., Stella, N., Calignano, A., Lin, S.Y., Makriyannis, A. & Piomelli, D. (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277, 1094-1097.
13. Bender, V.A., Bender, K.J., Brasier, D.J. & Feldman, D.E. (2006) Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex. J. Neurosci., 26, 4166-4177.
14. Bienenstock, E.L., Cooper, L.N. & Munro, P.W. (1982) Theory for the development of neuron selectivity: orientation specificity and binocular interaction in visual cortex. J. Neurosci., 2, 32-48.
15. Blankman, J.L., Simon, G.M. & Cravatt, B.F. (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol., 14, 1347-1356.
16. Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., Maffrand, J.P., Le Fur, G. & Casellas, P. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J. Biol. Chem., 272, 22330-22339.
17. Busquets-Garcia, A., Gomis-Gonzalez, M., Guegan, T., Agustin-Pavon, C., Pastor, A., Mato, S., Perez-Samartin, A., Matute, C., de la Torre, R., Dierssen, M., Maldonado, R. & Ozaita, A. (2013) Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat. Med., 19, 603-607.
18. Cadas, H., Gaillet, S., Beltramo, M., Venance, L. & Piomelli, D. (1996) Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neurosci., 16, 3934-3942.
19. Calabresi, P., Picconi, B., Tozzi, A. & Di Filippo, M. (2007) Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci., 30, 211-219.
20. Carlson, G., Wang, Y. & Alger, B.E. (2002) Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci., 5, 723-724.
21. Cassano, T., Gaetani, S., Macheda, T., Laconca, L., Romano, A., Morgese, M.G., Cimmino, C.S., Chiarotti, F., Bambico, F.R., Gobbi, G., Cuomo, V. & Piomelli, D. (2011) Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacology, 214, 465-476.
22. Castillo, P.E., Younts, T.J., Chavez, A.E. & Hashimotodani, Y. (2012) Endocannabinoid signaling and synaptic function. Neuron, 76, 70-81.
23. Chanda, P.K., Gao, Y., Mark, L., Btesh, J., Strassle, B.W., Lu, P., Piesla, M.J., Zhang, M.Y., Bingham, B., Uveges, A., Kowal, D., Garbe, D., Kouranova, E.V., Ring, R.H., Bates, B., Pangalos, M.N., Kennedy, J.D., Whiteside, G.T. & Samad, T.A. (2010) Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol. Pharmacol., 78, 996-1003.
24. Chavez, A.E., Chiu, C.Q. & Castillo, P.E. (2010) TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat. Neurosci., 13, 1511-1518.
25. Chevaleyre, V. & Castillo, P.E. (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron, 38, 461-472.
26. Chevaleyre, V. & Castillo, P.E. (2004) Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron, 43, 871-881.
27. Chevaleyre, V., Heifets, B.D., Kaeser, P.S., Sudhof, T.C. & Castillo, P.E. (2007) Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha. Neuron, 54, 801-812.
28. Childers, S.R. & Deadwyler, S.A. (1996) Role of cyclic AMP in the actions of cannabinoid receptors. Biochem. Pharmacol., 52, 819-827.
29. Chiu, C.Q., Puente, N., Grandes, P. & Castillo, P.E. (2010) Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J. Neurosci., 30, 7236-7248.
30. Choi, S.Y., Chang, J., Jiang, B., Seol, G.H., Min, S.S., Han, J.S., Shin, H.S., Gallagher, M. & Kirkwood, A. (2005) Multiple receptors coupled to phospholipase C gate long-term depression in visual cortex. J. Neurosci., 25, 11433-11443.
31. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A. & Gilula, N.B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 83-87.
32. Cravatt, B.F., Demarest, K., Patricelli, M.P., Bracey, M.H., Giang, D.K., Martin, B.R. & Lichtman, A.H. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA, 98, 9371-9376.
33. Cristino, L., de Petrocellis, L., Pryce, G., Baker, D., Guglielmotti, V. & Di Marzo, V. (2006) Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience, 139, 1405-1415.
34. Crosby, K.M., Inoue, W., Pittman, Q.J. & Bains, J.S. (2011) Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits. Neuron, 71, 529-541.
35. De-May, C.L. & Ali, A.B. (2013) Cell type-specific regulation of inhibition via cannabinoid type 1 receptors in rat neocortex. J. Neurophysiol., 109, 216-224.
36. Depoy, L., Daut, R., Brigman, J.L., Macpherson, K., Crowley, N., Gunduz-Cinar, O., Pickens, C.L., Cinar, R., Saksida, L.M., Kunos, G., Lovinger, D.M., Bussey, T.J., Camp, M.C. & Holmes, A. (2013) Chronic alcohol produces neuroadaptations to prime dorsal striatal learning. Proc. Natl. Acad. Sci. USA, 110, 14783-14788.
37. Derkinderen, P., Toutant, M., Burgaya, F., Le Bert, M., Siciliano, J.C., de Franciscis, V., Gelman, M. & Girault, J.A. (1996) Regulation of a neuronal form of focal adhesion kinase by anandamide. Science, 273, 1719-1722.
38. Devane, W.A., Dysarz, F.A. 3rd., Johnson, M.R., Melvin, L.S. & Howlett, A.C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol., 34, 605-613.
39. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
40. Di Marzo, V. (2009) The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol. Res., 60, 77-84.
41. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.C. & Piomelli, D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372, 686-691.
42. Dinh, T.P., Carpenter, D., Leslie, F.M., Freund, T.F., Katona, I., Sensi, S.L., Kathuria, S. & Piomelli, D. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. USA, 99, 10819-10824.
43. Dittman, J.S., Kreitzer, A.C. & Regehr, W.G. (2000) Interplay between facilitation, depression, and residual calcium at three presynaptic terminals. J. Neurosci., 20, 1374-1385.
44. Edwards, D.A., Kim, J. & Alger, B.E. (2006) Multiple mechanisms of endocannabinoid response initiation in hippocampus. J. Neurophysiol., 95, 67-75.
45. Edwards, D.A., Zhang, L. & Alger, B.E. (2008) Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus. Proc. Natl. Acad. Sci. USA, 105, 8142-8147.
46. Ekstrom, A.D., Meltzer, J., McNaughton, B.L. & Barnes, C.A. (2001) NMDA receptor antagonism blocks experience-dependent expansion of hippocampal 'place fields'. Neuron, 31, 631-638.
47. Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G. & Piomelli, D. (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J. Pharmacol. Exp. Ther., 313, 352-358.
48. Fino, E., Paille, V., Cui, Y., Morera-Herreras, T., Deniau, J.M. & Venance, L. (2010) Distinct coincidence detectors govern the corticostriatal spike timing-dependent plasticity. J. Physiol., 588, 3045-3062.
49. Foldy, C., Malenka, R.C. & Sudhof, T.C. (2013) Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron, 78, 498-509.
50. Fortune, E.S. & Rose, G.J. (2001) Short-term synaptic plasticity as a temporal filter. Trends Neurosci., 24, 381-385.
51. Freund, L.S. & Reiss, A.L. (1991) Cognitive profiles associated with the fra(X) syndrome in males and females. Am. J. Med. Genet., 38, 542-547.
52. Galve-Roperh, I., Sanchez, C., Cortes, M.L., Gomez del Pulgar, T., Izquierdo, M. & Guzman, M. (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med., 6, 313-319.
53. 2+ channel current. Am. J. Physiol., 276, H2085-H2093.
54. Giuffrida, A., Parsons, L.H., Kerr, T.M., Rodriguez de Fonseca, F., Navarro, M. & Piomelli, D. (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci., 2, 358-363.
55. Giuffrida, A., Beltramo, M. & Piomelli, D. (2001) Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J. Pharmacol. Exp. Ther., 298, 7-14.
56. Grueter, B.A., Brasnjo, G. & Malenka, R.C. (2010) Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat. Neurosci., 13, 1519-1525.
57. Hajos, N., Ledent, C. & Freund, T.F. (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience, 106, 1-4.
58. Hansen, H.H., Hansen, S.H., Schousboe, A. & Hansen, H.S. (2000) Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons. J. Neurochem., 75, 861-871.
59. 2+ dependency for triggering retrograde endocannabinoid signal. Neuron, 45, 257-268.
60. Hasselmo, M.E. (1995) Neuromodulation and cortical function: modeling the physiological basis of behavior. Behav. Brain Res., 67, 1-27.
61. Heifets, B.D. & Castillo, P.E. (2009) Endocannabinoid signaling and long-term synaptic plasticity. Annu. Rev. Physiol., 71, 283-306.
62. Hentges, S.T., Low, M.J. & Williams, J.T. (2005) Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J. Neurosci., 25, 9746-9751.
63. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R. & Rice, K.C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11, 563-583.
64. Hillard, C.J. (2000) Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostag. Oth. Lipid M., 61, 3-18.
65. Hillard, C.J. & Jarrahian, A. (2000) The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids, 108, 123-134.
66. Hoffman, A.F., Oz, M., Caulder, T. & Lupica, C.R. (2003) Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J. Neurosci., 23, 4815-4820.
67. Hoffman, A.F., Laaris, N., Kawamura, M., Masino, S.A. & Lupica, C.R. (2010) Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J. Neurosci., 30, 545-555.
68. Howlett, A.C. (2002) The cannabinoid receptors. Prostag. Oth. Lipid M., 68-69, 619-631.
69. Howlett, A.C., Bidaut-Russell, M., Devane, W.A., Melvin, L.S., Johnson, M.R. & Herkenham, M. (1990) The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci., 13, 420-423.
70. Howlett, A.C., Barth, F., Bonner, T.I., Cabral, G., Casellas, P., Devane, W.A., Felder, C.C., Herkenham, M., Mackie, K., Martin, B.R., Mechoulam, R. & Pertwee, R.G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202.
71. Huang, Y.C., Wang, S.J., Chiou, L.C. & Gean, P.W. (2003) Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala. J. Neurosci., 23, 10311-10320.
72. Huang, C.C., Lin, H.J. & Hsu, K.S. (2007) Repeated cocaine administration promotes long-term potentiation induction in rat medial prefrontal cortex. Cereb. Cortex, 17, 1877-1888.
73. Huang, S., Trevino, M., He, K., Ardiles, A., Pasquale, R., Guo, Y., Palacios, A., Huganir, R. & Kirkwood, A. (2012) Pull-push neuromodulation of LTP and LTD enables bidirectional experience-induced synaptic scaling in visual cortex. Neuron, 73, 497-510.
74. Ishikawa, M., Otaka, M., Huang, Y.H., Neumann, P.A., Winters, B.D., Grace, A.A., Schluter, O.M. & Dong, Y. (2013) Dopamine triggers heterosynaptic plasticity. J. Neurosci., 33, 6759-6765.
75. Isokawa, M. & Alger, B.E. (2005) Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell. J. Physiol., 567, 1001-1010.
76. Jhaveri, M.D., Richardson, D., Robinson, I., Garle, M.J., Patel, A., Sun, Y., Sagar, D.R., Bennett, A.J., Alexander, S.P., Kendall, D.A., Barrett, D.A. & Chapman, V. (2008) Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain. Neuropharmacology, 55, 85-93.
77. Jonsson, K.O., Holt, S. & Fowler, C.J. (2006) The endocannabinoid system: current pharmacological research and therapeutic possibilities. Basic Clin. Pharmacol., 98, 124-134.
78. Jung, K.M., Mangieri, R., Stapleton, C., Kim, J., Fegley, D., Wallace, M., Mackie, K. & Piomelli, D. (2005) Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol. Pharmacol., 68, 1196-1202.
79. Jung, K.M., Sepers, M., Henstridge, C.M., Lassalle, O., Neuhofer, D., Martin, H., Ginger, M., Frick, A., DiPatrizio, N.V., Mackie, K., Katona, I., Piomelli, D. & Manzoni, O.J. (2012) Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat. Commun., 3, 1080.
80. Karl, T., Cheng, D., Garner, B. & Arnold, J.C. (2012) The therapeutic potential of the endocannabinoid system for Alzheimer's disease. Expert Opin. Ther. Tar., 16, 407-420.
81. Kasanetz, F., Lafourcade, M., Deroche-Gamonet, V., Revest, J.M., Berson, N., Balado, E., Fiancette, J.F., Renault, P., Piazza, P.V. & Manzoni, O.J. (2012) Prefrontal synaptic markers of cocaine addiction-like behavior in rats. Mol. Psychiatr., 18, 729-737.
82. Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., La Rana, G., Calignano, A., Giustino, A., Tattoli, M., Palmery, M., Cuomo, V. & Piomelli, D. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med., 9, 76-81.
83. Katona, I. & Freund, T.F. (2012) Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci., 35, 529-558.
84. Kim, J., Isokawa, M., Ledent, C. & Alger, B.E. (2002) Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J. Neurosci., 22, 10182-10191.
85. Klyachko, V.A. & Stevens, C.F. (2006) Excitatory and feed-forward inhibitory hippocampal synapses work synergistically as an adaptive filter of natural spike trains. PLoS Biol., 4, e207.
86. Kortleven, C., Fasano, C., Thibault, D., Lacaille, J.C. & Trudeau, L.E. (2011) The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice. Eur. J. Neurosci., 33, 1751-1760.
87. Kreitzer, A.C. & Malenka, R.C. (2005) Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J. Neurosci., 25, 10537-10545.
88. Kreitzer, A.C. & Regehr, W.G. (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron, 29, 717-727.
89. Kunos, G., Batkai, S., Offertaler, L., Mo, F., Liu, J., Karcher, J. & Harvey-White, J. (2002) The quest for a vascular endothelial cannabinoid receptor. Chem. Phys. Lipids, 121, 45-56.
90. Lafourcade, M., Elezgarai, I., Mato, S., Bakiri, Y., Grandes, P. & Manzoni, O.J. (2007) Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS ONE, 2, e709.
91. Lafourcade, M., Larrieu, T., Mato, S., Duffaud, A., Sepers, M., Matias, I., De Smedt-Peyrusse, V., Labrousse, V.F., Bretillon, L., Matute, C., Rodriguez-Puertas, R., Laye, S. & Manzoni, O.J. (2011) Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci., 14, 345-350.
92. Lee, S.H. & Dan, Y. (2012) Neuromodulation of brain states. Neuron, 76, 209-222.
93. Lerner, T.N. & Kreitzer, A.C. (2012) RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. Neuron, 73, 347-359.
94. Lerner, T.N., Horne, E.A., Stella, N. & Kreitzer, A.C. (2010) Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists. J. Neurosci., 30, 2160-2164.
95. Lewis, J.E. & Maler, L. (2002) Dynamics of electrosensory feedback: short-term plasticity and inhibition in a parallel fiber pathway. J. Neurophysiol., 88, 1695-1706.
96. Maccarrone, M., Rossi, S., Bari, M., De Chiara, V., Rapino, C., Musella, A., Bernardi, G., Bagni, C. & Centonze, D. (2010) Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology, 35, 1500-1509.
97. Mackie, K. & Hille, B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA, 89, 3825-3829.
98. Mackie, K., Lai, Y., Westenbroek, R. & Mitchell, R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci., 15, 6552-6561.
99. Marco, E.M. & Laviola, G. (2012) The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives. J. Psychopharmacol., 26, 150-163.
100. Marinelli, S., Di Marzo, V., Florenzano, F., Fezza, F., Viscomi, M.T., van der Stelt, M., Bernardi, G., Molinari, M., Maccarrone, M. & Mercuri, N.B. (2007) N-Arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology, 32, 298-308.
101. Marinelli, S., Pacioni, S., Bisogno, T., Di Marzo, V., Prince, D.A., Huguenard, J.R. & Bacci, A. (2008) The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. J. Neurosci., 28, 13532-13541.
102. Marinelli, S., Pacioni, S., Cannich, A., Marsicano, G. & Bacci, A. (2009) Self-modulation of neocortical pyramidal neurons by endocannabinoids. Nat. Neurosci., 12, 1488-1490.
103. Marrs, W.R., Blankman, J.L., Horne, E.A., Thomazeau, A., Lin, Y.H., Coy, J., Bodor, A.L., Muccioli, G.G., Hu, S.S., Woodruff, G., Fung, S., Lafourcade, M., Alexander, J.P., Long, J.Z., Li, W., Xu, C., Moller, T., Mackie, K., Manzoni, O.J., Cravatt, B.F. & Stella, N. (2010) The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat. Neurosci., 13, 951-957.
104. Marsicano, G. & Lutz, B. (2006) Neuromodulatory functions of the endocannabinoid system. J. Endocrinol. Invest., 29, 27-46.
105. Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G., Hermann, H., Tang, J., Hofmann, C., Zieglgansberger, W., Di Marzo, V. & Lutz, B. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature, 418, 530-534.
106. Mathur, B.N., Tanahira, C., Tamamaki, N. & Lovinger, D.M. (2013) Voltage drives diverse endocannabinoid signals to mediate striatal microcircuit-specific plasticity. Nat. Neurosci., 16, 1275-1283.
107. Mato, S., Chevaleyre, V., Robbe, D., Pazos, A., Castillo, P.E. & Manzoni, O.J. (2004) A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. Nat. Neurosci., 7, 585-586.
108. Mato, S., Robbe, D., Puente, N., Grandes, P. & Manzoni, O.J. (2005) Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta9-tetrahydrocannabinol exposure. J. Neurosci., 25, 11619-11627.
109. Mazzola, C., Medalie, J., Scherma, M., Panlilio, L.V., Solinas, M., Tanda, G., Drago, F., Cadet, J.L., Goldberg, S.R. & Yasar, S. (2009) Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn. Memory, 16, 332-337.
110. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J. & Vogel, Z. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 83-90.
111. Melis, M., Perra, S., Muntoni, A.L., Pillolla, G., Lutz, B., Marsicano, G., Di Marzo, V., Gessa, G.L. & Pistis, M. (2004a) Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci., 24, 10707-10715.
112. Melis, M., Pistis, M., Perra, S., Muntoni, A.L., Pillolla, G. & Gessa, G.L. (2004b) Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci., 24, 53-62.
113. Melis, M., Pillolla, G., Luchicchi, A., Muntoni, A.L., Yasar, S., Goldberg, S.R. & Pistis, M. (2008) Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. J. Neurosci., 28, 13985-13994.
114. Min, R. & Nevian, T. (2012) Astrocyte signaling controls spike timing-dependent depression at neocortical synapses. Nat. Neurosci., 15, 746-753.
115. Molina-Holgado, F., Lledo, A. & Guaza, C. (1997) Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes. NeuroReport, 8, 1929-1933.
116. Montgomery, J.M. & Madison, D.V. (2002) State-dependent heterogeneity in synaptic depression between pyramidal cell pairs. Neuron, 33, 765-777.
117. Montgomery, J.M. & Madison, D.V. (2004) Discrete synaptic states define a major mechanism of synapse plasticity. Trends Neurosci., 27, 744-750.
118. Nazzaro, C., Greco, B., Cerovic, M., Baxter, P., Rubino, T., Trusel, M., Parolaro, D., Tkatch, T., Benfenati, F., Pedarzani, P. & Tonini, R. (2012) SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. Nat. Neurosci., 15, 284-293.
119. Neu, A., Foldy, C. & Soltesz, I. (2007) Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J. Physiol., 578, 233-247.
120. 2+ signaling in spike-timing-dependent plasticity. J. Neurosci., 26, 11001-11013.
121. Ohno-Shosaku, T., Maejima, T. & Kano, M. (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron, 29, 729-738.
122. Ohno-Shosaku, T., Shosaku, J., Tsubokawa, H. & Kano, M. (2002) Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur. J. Neurosci., 15, 953-961.
123. Ohno-Shosaku, T., Matsui, M., Fukudome, Y., Shosaku, J., Tsubokawa, H., Taketo, M.M., Manabe, T. & Kano, M. (2003) Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur. J. Neurosci., 18, 109-116.
124. Ohno-Shosaku, T., Hashimotodani, Y., Maejima, T. & Kano, M. (2005) Calcium signaling and synaptic modulation: regulation of endocannabinoid-mediated synaptic modulation by calcium. Cell Calcium, 38, 369-374.
125. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T. & Ueda, N. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem., 279, 5298-5305.
126. Oleson, E.B., Beckert, M.V., Morra, J.T., Lansink, C.S., Cachope, R., Abdullah, R.A., Loriaux, A.L., Schetters, D., Pattij, T., Roitman, M.F., Lichtman, A.H. & Cheer, J.F. (2012a) Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron, 73, 360-373.
127. Oleson, E.B., Gentry, R.N., Chioma, V.C. & Cheer, J.F. (2012b) Subsecond dopamine release in the nucleus accumbens predicts conditioned punishment and its successful avoidance. J. Neurosci., 32, 14804-14808.
128. Oleson, E.B., Cachope, R., Fitoussi, A. & Cheer, J.F. (2013) Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone? Prog. Neuropsychoph., doi: 10.1016/j.pnpbp.2013.07.019. [Epub ahead of print].
129. Oliet, S.H., Baimoukhametova, D.V., Piet, R. & Bains, J.S. (2007) Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing. J. Neurosci., 27, 1325-1333.
130. Onaivi, E.S. (2006) Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology, 54, 231-246.
131. O'Sullivan, S.E. (2007) Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Brit. J. Pharmacol., 152, 576-582.
132. Pan, B., Hillard, C.J. & Liu, Q.S. (2008a) D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J. Neurosci., 28, 14018-14030.
133. Pan, B., Hillard, C.J. & Liu, Q.S. (2008b) Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J. Neurosci., 28, 1385-1397.
134. Paradisi, A., Oddi, S. & Maccarrone, M. (2006) The endocannabinoid system in ageing: a new target for drug development. Curr. Drug Targets, 7, 1539-1552.
135. Pertwee, R.G. (2012) Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos. T. Roy. Soc. B., 367, 3353-3363.
136. Petrosino, S. & Di Marzo, V. (2010) FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr. Opin. Invest. Dr., 11, 51-62.
137. Picconi, B., Centonze, D., Hakansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M.A. & Calabresi, P. (2003) Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat. Neurosci., 6, 501-506.
138. Piomelli, D. (2003) The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci., 4, 873-884.
139. Puente, N., Cui, Y., Lassalle, O., Lafourcade, M., Georges, F., Venance, L., Grandes, P. & Manzoni, O.J. (2011) Polymodal activation of the endocannabinoid system in the extended amygdala. Nat. Neurosci., 14, 1542-1547.
140. Robbe, D., Alonso, G., Duchamp, F., Bockaert, J. & Manzoni, O.J. (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci., 21, 109-116.
141. Robbe, D., Kopf, M., Remaury, A., Bockaert, J. & Manzoni, O.J. (2002) Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. USA, 99, 8384-8388.
142. Robbe, D., Alonso, G. & Manzoni, O.J. (2003) Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens. Ann. NY Acad. Sci., 1003, 212-225.
143. Rodriguez-Moreno, A. & Paulsen, O. (2008) Spike timing-dependent long-term depression requires presynaptic NMDA receptors. Nat. Neurosci., 11, 744-745.
144. Ronesi, J. & Lovinger, D.M. (2005) Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. J. Physiol., 562, 245-256.
145. Rueda, D., Navarro, B., Martinez-Serrano, A., Guzman, M. & Galve-Roperh, I. (2002) The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. J. Biol. Chem., 277, 46645-46650.
146. Sagar, D.R., Kendall, D.A. & Chapman, V. (2008) Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain. Brit. J. Pharmacol., 155, 1297-1306.
147. Sanders, S.J., Ercan-Sencicek, A.G., Hus, V., Luo, R., Murtha, M.T., Moreno-De-Luca, D., Chu, S.H., Moreau, M.P., Gupta, A.R., Thomson, S.A., Mason, C.E., Bilguvar, K., Celestino-Soper, P.B., Choi, M., Crawford, E.L., Davis, L., Wright, N.R., Dhodapkar, R.M., DiCola, M., DiLullo, N.M., Fernandez, T.V., Fielding-Singh, V., Fishman, D.O., Frahm, S., Garagaloyan, R., Goh, G.S., Kammela, S., Klei, L., Lowe, J.K., Lund, S.C., McGrew, A.D., Meyer, K.A., Moffat, W.J., Murdoch, J.D., O'Roak, B.J., Ober, G.T., Pottenger, R.S., Raubeson, M.J., Song, Y., Wang, Q., Yaspan, B.L., Yu, T.W., Yurkiewicz, I.R., Beaudet, A.L., Cantor, R.M., Curland, M., Grice, D.E., Gunel, M., Lifton, R.P., Mane, S.M., Martin, D.M., Shaw, C.A., Sheldon, M., Tischfield, J.A., Walsh, C.A., Morrow, E.M., Ledbetter, D.H., Fombonne, E., Lord, C., Martin, C.L., Brooks, A.I., Sutcliffe, J.S., Cook, E.H. Jr., Geschwind, D., Roeder, K., Devlin, B. & State, M.W. (2011) Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron, 70, 863-885.
148. Savinainen, J.R., Saario, S.M. & Laitinen, J.T. (2012) The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiol. (Oxf.), 204, 267-276.
149. Scheiderer, C.L., Dobrunz, L.E. & McMahon, L.L. (2004) Novel form of long-term synaptic depression in rat hippocampus induced by activation of alpha 1 adrenergic receptors. J. Neurophysiol., 91, 1071-1077.
150. Schlosburg, J.E., Blankman, J.L., Long, J.Z., Nomura, D.K., Pan, B., Kinsey, S.G., Nguyen, P.T., Ramesh, D., Booker, L., Burston, J.J., Thomas, E.A., Selley, D.E., Sim-Selley, L.J., Liu, Q.S., Lichtman, A.H. & Cravatt, B.F. (2010) Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat. Neurosci., 13, 1113-1119.
151. Schultz, W. (1998) Predictive reward signal of dopamine neurons. J. Neurophysiol., 80, 1-27.
152. Seol, G.H., Ziburkus, J., Huang, S., Song, L., Kim, I.T., Takamiya, K., Huganir, R.L., Lee, H.K. & Kirkwood, A. (2007) Neuromodulators control the polarity of spike-timing-dependent synaptic plasticity. Neuron, 55, 919-929.
153. Shen, W., Flajolet, M., Greengard, P. & Surmeier, D.J. (2008) Dichotomous dopaminergic control of striatal synaptic plasticity. Science, 321, 848-851.
154. Shin, R.M., Tully, K., Li, Y., Cho, J.H., Higuchi, M., Suhara, T. & Bolshakov, V.Y. (2010) Hierarchical order of coexisting pre- and postsynaptic forms of long-term potentiation at synapses in amygdala. Proc. Natl. Acad. Sci. USA, 107, 19073-19078.
155. Sjostrom, P.J., Turrigiano, G.G. & Nelson, S.B. (2003) Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron, 39, 641-654.
156. Stella, N. & Piomelli, D. (2001) Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur. J. Pharmacol., 425, 189-196.
157. Stella, N., Schweitzer, P. & Piomelli, D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature, 388, 773-778.
158. Sugiura, T. & Waku, K. (2000) 2-Arachidonoylglycerol: a possible multifunctional lipid mediator in the nervous and immune systems. Ann. NY Acad. Sci., 905, 344-346.
159. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A. & Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Bioph. Res. Co., 215, 89-97.
160. Sumislawski, J.J., Ramikie, T.S. & Patel, S. (2011) Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Neuropsychopharmacology, 36, 2750-2761.
161. Sun, W. & Rebec, G.V. (2006) Repeated cocaine self-administration alters processing of cocaine-related information in rat prefrontal cortex. J. Neurosci., 26, 8004-8008.
162. Szabo, T., Biro, T., Gonzalez, A.F., Palkovits, M. & Blumberg, P.M. (2002) Pharmacological characterization of vanilloid receptor located in the brain. Brain Res. Mol. Brain Res., 98, 51-57.
163. Szallasi, A., Nilsson, S., Farkas-Szallasi, T., Blumberg, P.M., Hokfelt, T. & Lundberg, J.M. (1995) Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res., 703, 175-183.
164. Szczypka, M.S., Rainey, M.A., Kim, D.S., Alaynick, W.A., Marck, B.T., Matsumoto, A.M. & Palmiter, R.D. (1999) Feeding behavior in dopamine-deficient mice. Proc. Natl. Acad. Sci. USA, 96, 12138-12143.
165. Tonini, R., Ciardo, S., Cerovic, M., Rubino, T., Parolaro, D., Mazzanti, M. & Zippel, R. (2006) ERK-dependent modulation of cerebellar synaptic plasticity after chronic Delta9-tetrahydrocannabinol exposure. J. Neurosci., 26, 5810-5818.
166. Toth, A., Boczan, J., Kedei, N., Lizanecz, E., Bagi, Z., Papp, Z., Edes, I., Csiba, L. & Blumberg, P.M. (2005) Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res. Mol. Brain Res., 135, 162-168.
167. Twitchell, W., Brown, S. & Mackie, K. (1997) Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol., 78, 43-50.
168. Uchigashima, M., Narushima, M., Fukaya, M., Katona, I., Kano, M. & Watanabe, M. (2007) Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci., 27, 3663-3676.
169. Ueda, N., Puffenbarger, R.A., Yamamoto, S. & Deutsch, D.G. (2000) The fatty acid amide hydrolase (FAAH). Chem. Phys. Lipids, 108, 107-121.
170. Van Sickle, M.D., Duncan, M., Kingsley, P.J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J.S., Marnett, L.J., Di Marzo, V., Pittman, Q.J., Patel, K.D. & Sharkey, K.A. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science, 310, 329-332.
171. Varma, N., Carlson, G.C., Ledent, C. & Alger, B.E. (2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J. Neurosci., 21, RC188.
172. Varma, N., Brager, D., Morishita, W., Lenz, R.A., London, B. & Alger, B. (2002) Presynaptic factors in the regulation of DSI expression in hippocampus. Neuropharmacology, 43, 550-562.
173. Wang, Z., Kai, L., Day, M., Ronesi, J., Yin, H.H., Ding, J., Tkatch, T., Lovinger, D.M. & Surmeier, D.J. (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron, 50, 443-452.
174. Wilson, R.I. & Nicoll, R.A. (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature, 410, 588-592.
175. Xi, Z.X., Peng, X.Q., Li, X., Song, R., Zhang, H.Y., Liu, Q.R., Yang, H.J., Bi, G.H., Li, J. & Gardner, E.L. (2011) Brain cannabinoid CB(2) receptors modulate cocaine's actions in mice. Nat. Neurosci., 14, 1160-1166.
176. Yin, H.H., Davis, M.I., Ronesi, J.A. & Lovinger, D.M. (2006) The role of protein synthesis in striatal long-term depression. J. Neurosci., 26, 11811-11820.
177. Zelcer, I., Cohen, H., Richter-Levin, G., Lebiosn, T., Grossberger, T. & Barkai, E. (2006) A cellular correlate of learning-induced metaplasticity in the hippocampus. Cereb. Cortex, 16, 460-468.
178. Zhang, L. & Alger, B.E. (2010) Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J. Neurosci., 30, 5724-5729.
179. Zhou, F.M., Liang, Y. & Dani, J.A. (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci., 4, 1224-1229.
180. Zhu, P.J. & Lovinger, D.M. (2005) Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala. J. Neurosci., 25, 6199-6207.
181. Zhu, P.J. & Lovinger, D.M. (2007) Persistent synaptic activity produces long-lasting enhancement of endocannabinoid modulation and alters long-term synaptic plasticity. J. Neurophysiol., 97, 4386-4389.
182. Zygmunt, P.M., Petersson, J., Andersson, D.A., Chuang, H., Sorgard, M., Di Marzo, V., Julius, D. & Hogestatt, E.D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.